InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（3 笔）
内部人交易记录
首席财务官已披露买入
2
已披露卖出
3
T+90 胜率
0%
T+90 平均收益
-25.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Emany Sravan Kumar, 首席财务官. Director active across 4 companies, notably Ironwood Pharmaceuticals INC. Aggregated, 20 disclosures have been logged. Breakdown: 2 buys · 3 sells. Total volume traded: €636k. Activity tracked since 6 December 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Emany Sravan Kumar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
23,855 股Common StockSEC:0001104659-26-074749:0
31,750 股0Common StockSEC:0001193125-26-140513:0
11,006 股0Common StockSEC:0001193125-26-076897:0
6,294 股@ US$27.10100.0% 占其流量Common StockSEC:0001193125-26-002448:0
53,750 股0Common StockSEC:0001104659-25-046868:0
80,000 股0Common StockSEC:0000950170-25-000624:0
11,001 股@ US$4.083.5% 占其流量Class A Common StockSEC:0000950170-24-129227:0
53,750 股0Common StockSEC:0001104659-24-065701:0
18,280 股@ US$6.649.1% 占其流量Class A Common StockSEC:0000950170-24-062372:0
37,120 股0Class A Common StockSEC:0000950170-24-029907:0
10,684 股@ US$9.387.5% 占其流量Class A Common StockSEC:0000950170-24-027128:0
标准退出：2024年6月2日 (T+90)
65,312 股0Class A Common StockSEC:0000950170-24-015545:0
41,332 股@ US$14.9046.4% 占其流量Class A Common StockSEC:0000950170-24-013817:0
85,000 股0Class A Common StockSEC:0001209191-24-001903:0
6,661 股@ US$9.444.7% 占其流量Class A Common StockSEC:0001209191-23-056023:0
177,570 股0Common StockSEC:0001104659-23-119212:0
36,072 股@ US$8.3268.2% 占其流量Class A Common StockSEC:0001209191-23-049781:0
标准退出：2023年12月14日 (T+90)
74,236 股0Class A Common StockSEC:0001209191-23-017878:0
6,578 股@ US$11.566.0% 占其流量Class A Common StockSEC:0001209191-22-058611:0
85,000 股0Class A Common StockSEC:0001209191-21-068513:0
20 条申报中的 20 条
About Emany Sravan Kumar
Emany Sravan Kumar is Chief Financial Officer. He has 20 filings in total, and across the 20 sampled recent filings, the reported amounts are EUR 374569 of buys and EUR 261413 of sells, with activity ranging from 2021-12-08 to 2026-06-16. The largest filings concern Ironwood Pharmaceuticals INC and Beam Therapeutics Inc., and the modal transaction nature is Attribution.
